(Press-News.org) SEATTLE, Wash. – Sept. 8, 2025 – A large portion of the global population with diabetes remains undiagnosed or is not receiving optimal care, according to a new study published in The Lancet Diabetes & Endocrinology. The Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine and a global network of collaborators conducted the analysis of the diabetes care cascade for all ages, both sexes, and 204 countries and territories from 2000 to 2023.
In 2023, an estimated 44% of people aged 15 and older with diabetes are unaware of their condition. Underdiagnosis was greatest among young adults—despite facing higher risks for long-term complications.
Among those who were diagnosed, 91% were on some form of pharmacological treatment. However, of those receiving treatment, only 42% had their blood sugar levels managed optimally. This translates to just 21% of all people with diabetes globally having their condition under optimal management.
Despite improvements over two decades, the research also found substantial regional diagnosis and treatment disparities, particularly in low- and middle-income countries. High-income North America had the highest rates of diagnosis, while high-income Asia Pacific showed the highest rates of treatment among diagnosed individuals. Southern Latin America had the highest rates of optimal blood sugar management among those treated. In contrast, Central sub-Saharan Africa faced the largest gaps in diagnosis, with less than 20% of people with diabetes being aware of their condition.
“By 2050, 1.3 billion people are expected to be living with diabetes, and if nearly half don’t know they have a serious and potentially deadly health condition, it could easily become a silent epidemic,” said Lauryn Stafford, first author and researcher at IHME.
Given the pace at which cases are rapidly rising, the research underscores the urgent need for investment in screening programs for younger populations and access to medications and glucose-monitoring tools, especially in underserved regions. In 2022, the WHO set a target to have 80% of people with diabetes clinically diagnosed by 2030.
The study was funded by the Bill & Melinda Gates Foundation.
For interviews with the researchers, journalists can email IHMEmedia@uw.edu.
Journalists: advanced copies of the paper, appendix, and datasets are available for download via this NextCloud folder.
This remains under embargo until 23.30 UK time on Monday, 8 September. Once live, you can access it online here: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00217-7/fulltext
END
Nearly half of those with diabetes unaware they have the disease
2025-09-08
ELSE PRESS RELEASES FROM THIS DATE:
Emergency department visits by uninsured children in Texas soar 45% after COVID-era federal funding ends
2025-09-08
As the COVID-19 pandemic wound down, so did the federal government’s funding to states that allowed all Medicaid enrollees to keep their coverage even if they no longer would have been eligible otherwise.
This “great unwinding” at the end of March 2023 meant that more than 25 million people—about 30 percent of all Medicaid recipients—were removed from the program.
Now, in the first study of its kind, researchers have analyzed how the unwinding affected the payer mix for children’s emergency department visits in Texas. During ...
Bright children from poorer backgrounds twice as likely to receive hospital mental health treatment than affluent high-achievers
2025-09-08
Bright children from poorer backgrounds are twice as likely to be admitted to hospital with mental health problems than high-achievers with affluent upbringings.
That’s according to a new study of tens of thousands of secondary school pupils in England, published today in the peer-reviewed journal Oxford Review of Education, which also demonstrates poorer teens are more likely to be treated for alcohol and drug use and self-harm.
The paper, funded by the Nuffield Foundation, shows too they are more likely to become pregnant.
The ...
‘Artificial cartilage’ could improve arthritis treatment
2025-09-08
Researchers have developed a material that can sense tiny changes within the body, such as during an arthritis flare-up, and release drugs exactly where and when they are needed.
The squishy material can be loaded with anti-inflammatory drugs that are released in response to small changes in pH in the body. During an arthritis flare-up, a joint becomes inflamed and slightly more acidic than the surrounding tissue.
The material, developed by researchers at the University of Cambridge, has been designed to respond to this natural change in pH. As acidity increases, the material becomes softer and more jelly-like, triggering the release of drug molecules that can be encapsulated ...
Breathing device could have profound impact on survival for people with sleep apnoea and type 2 diabetes
2025-09-08
People with both type 2 diabetes (T2D) and obstructive sleep apnoea have a higher risk of death, but treatment with continuous positive airway pressure (CPAP) may reduce that risk by around 26%, according to new research being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept).
The Swedish researchers said the results underscore the importance of treating sleep apnoea as part of a broader effort to control type 2 diabetes ...
Artificial intelligence assessment indicates stress levels in farmed Amazonian fish
2025-09-08
In Brazil, a group led by researchers from São Paulo State University (UNESP) in Jaboticabal, in collaboration with the Brazilian Agricultural Research Corporation (EMBRAPA), has developed an artificial intelligence (AI) tool to assess the stress levels of tambaqui (Colossoma macropomum), the most widely produced native fish in Brazil. The study was published in the journal Aquaculture.
The results could impact both animal welfare and the selection of specimens that are more tolerant of the farming environment. Tambaqui is an Amazonian species primarily farmed in the ...
Keith Cole receives grant to conduct integrated research on mobility, cognition and aging
2025-09-08
The five-year grant from the National Institute on Aging (NIA) will fund Cole’s research on dual decline while integrating advanced training in the pathophysiology of Alzheimer’s disease and related dementias, and systems biology of aging. Older adults experiencing dual decline are at greater risk of developing dementia than those with changes in only one area.
“Research into dual decline may help researchers identify predictors and treatment targets, potentially transforming early detection and intervention strategies for aging adults with an elevated risk of physical and cognitive decline,” ...
Internationally recognized malaria researcher Stefan Kappe, Ph.D., appointed new director of the UM School of Medicine's Center for Vaccine Development and Global Health
2025-09-08
University of Maryland School of Medicine Dean, Mark T. Gladwin, MD, announced today the appointment of distinguished parasitologist and immunologist Stefan Kappe, PhD, to be the new Director of the school’s Center for Vaccine Development and Global Health (CVD). He will also serve as the Myron M. Levine, MD, DTPH Professor of Vaccinology in the Department of Pediatrics.
Dr. Kappe is a Professor and the Associate Vice Chair of Basic Science Research in the Department of Pediatrics at the University of Washington in Seattle. He is also a senior principal investigator at the Center for Global ...
Lung cancer genetics study launches open-source data platform to research community
2025-09-08
23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the Lung Cancer Genetics Study. Launched in 2024, the Lung Cancer Genetics Study aims to enroll 10,000 individuals diagnosed with lung cancer by 2027. The study already includes more than 1,200 participants and is one of the most diverse cohorts ever assembled for lung cancer genetics research.
This marks a new phase in the study — with researchers now able to request access to de-identified data from consenting study participants and begin conducting analyses. This unique research program ...
Pre-conception radiation exposure from CT scans increases risk for miscarriage and birth defects
2025-09-08
Embargoed for release until 5:00 p.m. ET on Monday 8 September 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their ...
Boston University appoints Kenneth Lutchen to top research job
2025-09-08
Boston University has appointed pioneering biomedical engineer and experienced higher education leader Kenneth Lutchen as its new vice president and associate provost for research. He will lead BU’s $500 million research enterprise, which spurs new knowledge and impactful advances. In the past year alone, BU researchers have launched a global AI-powered infectious diseases monitoring tool, engineered devices that could improve cancer treatment, and landed a telescope on the moon.
Lutchen has held a variety of teaching and leadership positions since ...